BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 28756592)

  • 1. Evaluating the potential of circulating hTERT levels in glioma: can plasma levels serve as an independent prognostic marker?
    Gandhi P; Khare R; Garg N
    J Neurooncol; 2017 Nov; 135(2):255-261. PubMed ID: 28756592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Plasma miR-122 as a potential diagnostic and prognostic indicator in human glioma.
    Tang Y; Zhao S; Wang J; Li D; Ren Q; Tang Y
    Neurol Sci; 2017 Jun; 38(6):1087-1092. PubMed ID: 28367610
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Correlation of hTERT expression to maspin and bFGF expression and their significance in glioma].
    Wang DL; Wang YF; Shi GS; Huang H
    Ai Zheng; 2007 Jun; 26(6):601-6. PubMed ID: 17562265
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High CHI3L1 expression is associated with glioma patient survival.
    Steponaitis G; Skiriutė D; Kazlauskas A; Golubickaitė I; Stakaitis R; Tamašauskas A; Vaitkienė P
    Diagn Pathol; 2016 Apr; 11():42. PubMed ID: 27121858
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic significance of telomere maintenance mechanisms in pediatric high-grade gliomas.
    Dorris K; Sobo M; Onar-Thomas A; Panditharatna E; Stevenson CB; Gardner SL; Dewire MD; Pierson CR; Olshefski R; Rempel SA; Goldman S; Miles L; Fouladi M; Drissi R
    J Neurooncol; 2014 Mar; 117(1):67-76. PubMed ID: 24477622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Diagnostic and prognostic value of serum vitronectin levels in human glioma.
    Chen MH; Lu C; Sun J; Chen XD; Dai JX; Cai JY; Chen XL
    J Neurol Sci; 2016 Dec; 371():54-59. PubMed ID: 27871448
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating DNA is a useful prognostic factor in patients with advanced non-small cell lung cancer.
    Sirera R; Bremnes RM; Cabrera A; Jantus-Lewintre E; Sanmartín E; Blasco A; Del Pozo N; Rosell R; Guijarro R; Galbis J; Sánchez JJ; Camps C
    J Thorac Oncol; 2011 Feb; 6(2):286-90. PubMed ID: 21252717
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic role of high sensitivity C-reactive protein and interleukin-6 in glioma and meningioma patients.
    Bunevicius A; Radziunas A; Tamasauskas S; Tamasauskas A; Laws ER; Iervasi G; Bunevicius R; Deltuva V
    J Neurooncol; 2018 Jun; 138(2):351-358. PubMed ID: 29460097
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A panel of four cytokines predicts the prognosis of patients with malignant gliomas.
    Lin Y; Zhang G; Zhang J; Gao G; Li M; Chen Y; Wang J; Li G; Song SW; Qiu X; Wang Y; Jiang T
    J Neurooncol; 2013 Sep; 114(2):199-208. PubMed ID: 23748572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PinX1 is up-regulated and associated with poor patients' survival in gliomas.
    Bai J; Chen YS; Mei PJ; Liu QH; Du Y; Zheng JN
    Int J Clin Exp Pathol; 2015; 8(6):6952-9. PubMed ID: 26261583
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High level of Sema3C is associated with glioma malignancy.
    Vaitkienė P; Skiriutė D; Steponaitis G; Skauminas K; Tamašauskas A; Kazlauskas A
    Diagn Pathol; 2015 Jun; 10():58. PubMed ID: 26032848
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of serum microRNA-205 as a potential diagnostic and prognostic biomarker for human glioma.
    Yue X; Lan F; Hu M; Pan Q; Wang Q; Wang J
    J Neurosurg; 2016 Jan; 124(1):122-8. PubMed ID: 26230475
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Plasma microRNA-720 may predict prognosis and diagnosis in glioma patients.
    Chen P; Zhang G; Zhou Q; Li Z
    Biosci Rep; 2020 Jul; 40(7):. PubMed ID: 32639004
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Down-regulation of Nedd4L is associated with the aggressive progression and worse prognosis of malignant glioma.
    He S; Deng J; Li G; Wang B; Cao Y; Tu Y
    Jpn J Clin Oncol; 2012 Mar; 42(3):196-201. PubMed ID: 22217575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Telomerase as a prognostic marker in breast cancer: high-throughput tissue microarray analysis of hTERT and hTR.
    Poremba C; Heine B; Diallo R; Heinecke A; Wai D; Schaefer KL; Braun Y; Schuck A; Lanvers C; Bànkfalvi A; Kneif S; Torhorst J; Zuber M; Köchli OR; Mross F; Dieterich H; Sauter G; Stein H; Fogt F; Boecker W
    J Pathol; 2002 Oct; 198(2):181-9. PubMed ID: 12237877
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acylglycerol kinase functions as an oncogene and an unfavorable prognostic marker of human gliomas.
    Liu N; Wang Z; Cheng Y; Zhang P; Wang X; Yang H; Liu H; Zhang Y; Tu Y
    Hum Pathol; 2016 Dec; 58():105-112. PubMed ID: 27574811
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Alternative splicing of human telomerase reverse transcriptase in gliomas and its modulation mediated by CX-5461.
    Li G; Shen J; Cao J; Zhou G; Lei T; Sun Y; Gao H; Ding Y; Xu W; Zhan Z; Chen Y; Huang H
    J Exp Clin Cancer Res; 2018 Apr; 37(1):78. PubMed ID: 29631594
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Histone H1.0--a potential molecular marker with prognostic value for patients with malignant gliomas.
    Gabrovsky N; Georgieva M; Laleva M; Uzunov K; Miloshev G
    Acta Neurochir (Wien); 2013 Aug; 155(8):1437-42. PubMed ID: 23812966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Downregulation of microRNA-504 is associated with poor prognosis in high-grade glioma.
    Guan Y; Chen L; Bao Y; Pang C; Cui R; Li G; Liu J; Wang Y
    Int J Clin Exp Pathol; 2015; 8(1):727-34. PubMed ID: 25755767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. SHOX2 is a Potent Independent Biomarker to Predict Survival of WHO Grade II-III Diffuse Gliomas.
    Zhang YA; Zhou Y; Luo X; Song K; Ma X; Sathe A; Girard L; Xiao G; Gazdar AF
    EBioMedicine; 2016 Nov; 13():80-89. PubMed ID: 27840009
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.